BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

652 related articles for article (PubMed ID: 15210528)

  • 1. Anti-glutamic acid decarboxylase antibodies in the serum and cerebrospinal fluid of patients with stiff-person syndrome: correlation with clinical severity.
    Rakocevic G; Raju R; Dalakas MC
    Arch Neurol; 2004 Jun; 61(6):902-4. PubMed ID: 15210528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association.
    Saiz A; Blanco Y; Sabater L; González F; Bataller L; Casamitjana R; Ramió-Torrentà L; Graus F
    Brain; 2008 Oct; 131(Pt 10):2553-63. PubMed ID: 18687732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic usefulness of glutamic acid decarboxylase antibodies in stiff-man syndrome].
    Saiz A; Arias M; Fernández-Barreiro A; Mínguez A; Casamitjana R; Tolosa E; Graus F
    Med Clin (Barc); 1998 Mar; 110(10):378-81. PubMed ID: 9567281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies.
    Dalakas MC; Li M; Fujii M; Jacobowitz DM
    Neurology; 2001 Sep; 57(5):780-4. PubMed ID: 11552003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful treatment in a patient with a focal form of stiff-person syndrome using plasma exchange and intravenous immunoglobulin therapy].
    Shiraishi H; Motomura M; Iwanaga H; Tsujino A; Nishiura Y; Shirabe S; Nakamura T; Yoshimura T
    Rinsho Shinkeigaku; 2002 Aug; 42(8):766-70. PubMed ID: 12701225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Qualitative and quantitative evidence of anti-glutamic acid decarboxylase-specific intrathecal antibody synthesis in patients with stiff person syndrome.
    Jarius S; Stich O; Speck J; Rasiah Ch; Wildemann B; Meinck HM; Rauer S
    J Neuroimmunol; 2010 Dec; 229(1-2):219-24. PubMed ID: 20813415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose intravenous immune globulin for stiff-person syndrome.
    Dalakas MC; Fujii M; Li M; Lutfi B; Kyhos J; McElroy B
    N Engl J Med; 2001 Dec; 345(26):1870-6. PubMed ID: 11756577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal stiff-person syndrome.
    Fiol M; Cammarota A; Rivero A; Pardal A; Nogués M; Correale J
    Neurologia; 2001 Feb; 16(2):89-91. PubMed ID: 11257937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of gamma-aminobutyric acid synthesis by glutamic acid decarboxylase autoantibodies in stiff-man syndrome.
    Dinkel K; Meinck HM; Jury KM; Karges W; Richter W
    Ann Neurol; 1998 Aug; 44(2):194-201. PubMed ID: 9708541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Stiff-person syndrome and other myelopathies constitute paraneoplastic neurological syndromes].
    Ishii A
    Brain Nerve; 2010 Apr; 62(4):377-85. PubMed ID: 20420178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rigidity and spasms from autoimmune encephalomyelopathies: stiff-person syndrome.
    Espay AJ; Chen R
    Muscle Nerve; 2006 Dec; 34(6):677-90. PubMed ID: 16969837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome.
    Chang T; Alexopoulos H; McMenamin M; Carvajal-González A; Alexander SK; Deacon R; Erdelyi F; Szabó G; Lang B; Blaes F; Brown P; Vincent A
    JAMA Neurol; 2013 Sep; 70(9):1140-9. PubMed ID: 23877118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies.
    Ali F; Rowley M; Jayakrishnan B; Teuber S; Gershwin ME; Mackay IR
    J Autoimmun; 2011 Sep; 37(2):79-87. PubMed ID: 21680149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.
    Skorstad G; Hestvik AL; Torjesen P; Alvik K; Vartdal F; Vandvik B; Holmøy T
    Eur J Neurol; 2008 Sep; 15(9):973-80. PubMed ID: 18637036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies.
    Dalakas MC
    J Neurol; 2005 May; 252 Suppl 1():I19-25. PubMed ID: 15959668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid T cell responses against glutamic acid decarboxylase 65 in patients with stiff person syndrome.
    Skorstad G; Hestvik AL; Vartdal F; Holmøy T
    J Autoimmun; 2009 Feb; 32(1):24-32. PubMed ID: 19027267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stiff-person syndrome: a case report].
    Cabo-López I; Negueruela-López M; García-Bermejo P; Zamarbide-Capdepon I; García-Ruiz PJ; Durán-Martínez P; González-Roiz C
    Rev Neurol; 2008 Sep 1-15; 47(5):249-52. PubMed ID: 18780271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamic acid decarboxylase autoantibodies and neurological disorders.
    Vianello M; Tavolato B; Giometto B
    Neurol Sci; 2002 Oct; 23(4):145-51. PubMed ID: 12536283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stiff-leg syndrome: a focal form of stiff-man syndrome.
    Saiz A; Graus F; Valldeoriola F; Valls-Solé J; Tolosa E
    Ann Neurol; 1998 Mar; 43(3):400-3. PubMed ID: 9506561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.